NCT03996564

Brief Summary

The randomized controlled study aims was to investigate the pain control of Battle Field Acupuncture as Primary or Adjunctive Treatment in Back Pain (Acute Musculoskeletal pain) in the (acute pain setting) Emergency Department vs stand of care pain medications.

Trial Health

100
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
26

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Feb 2016

Shorter than P25 for not_applicable

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

February 22, 2016

Completed
10 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 12, 2016

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 12, 2016

Completed
1.7 years until next milestone

First Submitted

Initial submission to the registry

September 7, 2018

Completed
10 months until next milestone

First Posted

Study publicly available on registry

June 25, 2019

Completed
Last Updated

June 26, 2019

Status Verified

June 1, 2019

Enrollment Period

10 months

First QC Date

September 7, 2018

Last Update Submit

June 24, 2019

Conditions

Keywords

Battlefield AcupunctureAuricular AcupunctureComplementary Alternative MedicineMilitary, Service MembersEmergency MedicineBack PainAcute Back PainChronic Back PainAlternative Medicine,

Outcome Measures

Primary Outcomes (3)

  • time-response of BFA, and the association with pain level using the Visual Analog scale (0-10 mm) scoring as well as the Numeric Rating Scale (0-10) scoring

    determine if there is any significant change in pain in the BFA treatment group at specific time points using the Visual Analog scale (0-10 mm) scoring as well as the Numeric Rating Scale (0-10) scoring

    before treatment, 30-40 minutes post-treatment, and 48 to 72 hours post-treatment

  • Evaluate the change of pain on Visual Analog scale (0-10mm) scoring with BFA administered in the emergency department for persons presenting with non-pathologic back pain.

    Using the Visual Analog scale which is a 10mm line, the patient will place a mark on the graph which will be measured to determine if there is any significant difference between the BFA treatment group pain at specific timepoints using the VAS. The lower the score determined on the scale corresponds to a lower pain level for the patient and a higher score corresponds to a higher pain level.

    baseline and at 30-40 minutes post treatment

  • Evaluate the change of pain on Numeric Rating Scale (0-10) scoring with BFA administered in the emergency department for persons presenting with non-pathologic back pain.

    The Numeric Rating scale which is a scale that is verbally asked to determine the patients pain response on a scale from 0 to 10 determine if there is any significant difference between the BFA treatment group pain at specific timepoints using the NRS. The lower the score determined on the scale corresponds to a lower pain level for the patient and a higher score corresponds to a higher pain level.

    baseline, 30-40 minutes, and 48-72 hours

Secondary Outcomes (4)

  • time-response

    30-40 minutes after treatment, and between 48-72 hours after discharge

  • Examine the functionality score changes at 3 time points using the Back Pain Functional Scale

    baseline, at the time the patient is to be discharged from the Emergency Room (0-3 hrs post baseline assessment), and 48-72 hours after discharge

  • Explore participant satisfaction of pain control in the BFA treatment group: 1 question

    At discharge from the Emergency Room (0-3 hours post baseline assessment) and between 48-72 hours after discharge

  • The need for any additional pain medication outside of the treatment protocol

    recorded at the 48-72 hours from discharge for the follow up interview

Study Arms (2)

Acupuncture Group

ACTIVE COMPARATOR

Battlefield Acupuncture (BFA) has a structured administration sequence that was utilized to limit any variability between investigators administering the treatment. The BFA technique has been suggested that the needles are placed not just in an acupoint but actually "acupoint zones." BFA utilizes one to ten (maximum five points per ear) ASP semi-permanent gold needles® placed in one or both ears. The ASP Gold needle® is a sterile device which inserts a small 2 mm needle into the auricle. It is comprised in single-needle applicator ensuring ease of insertion combined with excellent precision. The needles remain in the ear and fall out spontaneously as early as two hours and up to seven days. After administration of the BFA, if subjects felt that their pain was not controlled based on verbal response, rescue medication could be administered to control pain to a tolerable level for discharge.

Device: Battlefield Acupuncture

Standard Care Group

ACTIVE COMPARATOR

Participants randomized to the standard care group were treated with one, or a combination of selected medications to include oral Acetaminophen 500mg-1000mg, Diclofenac 50mg-75 mg orally, Diazepam 5mg-10 mg intravenous or oral, Hydrocodone 5mg/325mg-10mg/650mg mg oral, or intramuscular Ketorolac 30mg-60 mg, as deemed appropriate by the treating investigator (medical provider). Standard treatment was administered by the investigators based on the patient's presentation and driving status as many of the medications cannot be administered if the subject would operate a vehicle. No standardized algorithm was specified and the route and dose of medications was administered at the provider's discretion. After administration of the traditional standard care medications, if subjects felt their pain was not controlled based on verbal responses, rescue medication would be given to control pain to a more tolerable level for discharge.

Drug: AcetaminophenDrug: DiclofenacDrug: DiazepamDrug: HydrocodoneDrug: Ketorolac

Interventions

1-10 needles inserted in systematic nature as described by Battlefield acupuncture protocol.

Acupuncture Group

Acetaminophen 500mg-1000mg,

Also known as: Tylenol
Standard Care Group

Diclofenac 50mg-75 mg orally

Also known as: Voltaren
Standard Care Group

Diazepam 5mg-10 mg intravenous or oral

Also known as: Valium
Standard Care Group

Hydrocodone 5mg/325mg-10mg/650mg mg

Also known as: Norco
Standard Care Group

oral, or intramuscular Ketorolac 30mg-60 mg

Also known as: Toradol
Standard Care Group

Eligibility Criteria

Age18 Years - 55 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Individuals to be enrolled the study will be:
  • Emergency Room patient
  • Able to provide informed consent (of sound mind)
  • acute defined as less than 3 months, or acute on chronic musculoskeletal pain
  • Individuals will be between 18-55 years of age and include Active Duty (AD) service members and beneficiaries
  • Pain at prescreening will be greater than or equal to 3 based on the Visual Analogue Scale (VAS).
  • Non-pathological acute back pain

You may not qualify if:

  • Participants presenting with open wound injuries
  • temperature \>38.0 Celsius
  • suspected fractures
  • pain associated with diseases (flank/kidney pain)
  • concern for other than back pain (pyelonephritis, kidney stones, pathologic signs and symptoms)
  • bowel/bladder incontinence or retention
  • foot drop
  • known current/history of cancer
  • known bleeding disorders
  • active infection at the needled insertion site
  • If member is found to be pregnant at any time during screening process they will be removed from consideration before any treatment options are offered.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Related Publications (27)

  • Buckenmaier CC 3rd, Rupprecht C, McKnight G, McMillan B, White RL, Gallagher RM, Polomano R. Pain following battlefield injury and evacuation: a survey of 110 casualties from the wars in Iraq and Afghanistan. Pain Med. 2009 Nov;10(8):1487-96. doi: 10.1111/j.1526-4637.2009.00731.x. Epub 2009 Oct 14.

    PMID: 19843233BACKGROUND
  • Butler FK Jr, Kotwal RS, Buckenmaier CC 3rd, Edgar EP, O'Connor KC, Montgomery HR, Shackelford SA, Gandy JV, Wedmore I, Timby JW, Gross K, Bailey JA. A Triple-Option Analgesia Plan for Tactical Combat Casualty Care: TCCC Guidelines Change 13-04. J Spec Oper Med. 2014 Spring;14(1):13-25. doi: 10.55460/CBRW-A2G1.

    PMID: 24604434BACKGROUND
  • Burns, S., et al. (2013). "Moving Acupuncture to the Frontline of Military Medical Care: A Feasibility Study." Medical Acupuncture 25(1): 49-54.

    BACKGROUND
  • Chang BH, Sommers E. Acupuncture and relaxation response for craving and anxiety reduction among military veterans in recovery from substance use disorder. Am J Addict. 2014 Mar-Apr;23(2):129-36. doi: 10.1111/j.1521-0391.2013.12079.x. Epub 2013 Aug 30.

    PMID: 25187049BACKGROUND
  • Cohen SP, Griffith S, Larkin TM, Villena F, Larkin R. Presentation, diagnoses, mechanisms of injury, and treatment of soldiers injured in Operation Iraqi Freedom: an epidemiological study conducted at two military pain management centers. Anesth Analg. 2005 Oct;101(4):1098-1103. doi: 10.1213/01.ane.0000169332.45209.cf.

    PMID: 16192528BACKGROUND
  • Corwell BN. The emergency department evaluation, management, and treatment of back pain. Emerg Med Clin North Am. 2010 Nov;28(4):811-39. doi: 10.1016/j.emc.2010.06.001. Epub 2010 Aug 4.

    PMID: 20971393BACKGROUND
  • Delgado R, York A, Lee C, Crawford C, Buckenmaier C 3rd, Schoomaker E, Crawford P; Active Self-Care Therapies for Pain (PACT) Working Group. Assessing the quality, efficacy, and effectiveness of the current evidence base of active self-care complementary and integrative medicine therapies for the management of chronic pain: a rapid evidence assessment of the literature. Pain Med. 2014 Apr;15 Suppl 1:S9-20. doi: 10.1111/pme.12412.

    PMID: 24734865BACKGROUND
  • Gawande A. Casualties of war--military care for the wounded from Iraq and Afghanistan. N Engl J Med. 2004 Dec 9;351(24):2471-5. doi: 10.1056/NEJMp048317. No abstract available.

    PMID: 15590948BACKGROUND
  • Goertz CM, Niemtzow R, Burns SM, Fritts MJ, Crawford CC, Jonas WB. Auricular acupuncture in the treatment of acute pain syndromes: A pilot study. Mil Med. 2006 Oct;171(10):1010-4. doi: 10.7205/milmed.171.10.1010.

    PMID: 17076456BACKGROUND
  • Gondusky JS, Reiter MP. Protecting military convoys in Iraq: an examination of battle injuries sustained by a mechanized battalion during Operation Iraqi Freedom II. Mil Med. 2005 Jun;170(6):546-9. doi: 10.7205/milmed.170.6.546.

    PMID: 16001610BACKGROUND
  • Jones D, Shug S. Opioids in chronic pain of non-malignant origin: an interim consensus. N Z Med J. 1995 Nov 24;108(1012):492. No abstract available.

    PMID: 8538981BACKGROUND
  • Kim KH, Lee BR, Ryu JH, Choi TY, Yang GY. The role of acupuncture in emergency department settings: a systematic review. Complement Ther Med. 2013 Feb;21(1):65-72. doi: 10.1016/j.ctim.2012.12.004. Epub 2012 Dec 29.

    PMID: 23374207BACKGROUND
  • Lande RG. Sleep problems, posttraumatic stress, and mood disorders among active-duty service members. J Am Osteopath Assoc. 2014 Feb;114(2):83-9. doi: 10.7556/jaoa.2014.021.

    PMID: 24481800BACKGROUND
  • Lazar SG. The mental health needs of military service members and veterans. Psychodyn Psychiatry. 2014 Sep;42(3):459-78. doi: 10.1521/pdps.2014.42.3.459.

    PMID: 25211433BACKGROUND
  • Lew HL, Otis JD, Tun C, Kerns RD, Clark ME, Cifu DX. Prevalence of chronic pain, posttraumatic stress disorder, and persistent postconcussive symptoms in OIF/OEF veterans: polytrauma clinical triad. J Rehabil Res Dev. 2009;46(6):697-702. doi: 10.1682/jrrd.2009.01.0006.

    PMID: 20104399BACKGROUND
  • Outcalt SD, Ang DC, Wu J, Sargent C, Yu Z, Bair MJ. Pain experience of Iraq and Afghanistan Veterans with comorbid chronic pain and posttraumatic stress. J Rehabil Res Dev. 2014;51(4):559-70. doi: 10.1682/JRRD.2013.06.0134.

    PMID: 25144169BACKGROUND
  • Patel TH, Wenner KA, Price SA, Weber MA, Leveridge A, McAtee SJ. A U.S. Army Forward Surgical Team's experience in Operation Iraqi Freedom. J Trauma. 2004 Aug;57(2):201-7. doi: 10.1097/01.ta.0000133638.30269.38.

    PMID: 15345962BACKGROUND
  • Pennick V, Liddle SD. Interventions for preventing and treating pelvic and back pain in pregnancy. Cochrane Database Syst Rev. 2013 Aug 1;(8):CD001139. doi: 10.1002/14651858.CD001139.pub3.

    PMID: 23904227BACKGROUND
  • Pilkington K, Kirkwood G, Rampes H, Cummings M, Richardson J. Acupuncture for anxiety and anxiety disorders--a systematic literature review. Acupunct Med. 2007 Jun;25(1-2):1-10. doi: 10.1136/aim.25.1-2.1.

    PMID: 17641561BACKGROUND
  • Schug SA, Zech D, Grond S, Jung H, Meuser T, Stobbe B. A long-term survey of morphine in cancer pain patients. J Pain Symptom Manage. 1992 Jul;7(5):259-66. doi: 10.1016/0885-3924(92)90059-q.

    PMID: 1624812BACKGROUND
  • Seal KH, Shi Y, Cohen G, Cohen BE, Maguen S, Krebs EE, Neylan TC. Association of mental health disorders with prescription opioids and high-risk opioid use in US veterans of Iraq and Afghanistan. JAMA. 2012 Mar 7;307(9):940-7. doi: 10.1001/jama.2012.234.

    PMID: 22396516BACKGROUND
  • Seal KH, Metzler TJ, Gima KS, Bertenthal D, Maguen S, Marmar CR. Trends and risk factors for mental health diagnoses among Iraq and Afghanistan veterans using Department of Veterans Affairs health care, 2002-2008. Am J Public Health. 2009 Sep;99(9):1651-8. doi: 10.2105/AJPH.2008.150284. Epub 2009 Jul 16.

    PMID: 19608954BACKGROUND
  • Sharpe Potter J, Bebarta VS, Marino EN, Ramos RG, Turner BJ. Pain management and opioid risk mitigation in the military. Mil Med. 2014 May;179(5):553-8. doi: 10.7205/MILMED-D-13-00109.

    PMID: 24806501BACKGROUND
  • Tan HJ, Lan Y, Wu FS, Zhang HD, Wu L, Wu X, Liang FR. [Auricular acupuncture for primary insomnia: a systematic review based on GRADE system]. Zhongguo Zhen Jiu. 2014 Jul;34(7):726-30. Chinese.

    PMID: 25233674BACKGROUND
  • Vas J, Aranda-Regules JM, Modesto M, Aguilar I, Baron-Crespo M, Ramos-Monserrat M, Quevedo-Carrasco M, Rivas-Ruiz F. Auricular acupuncture for primary care treatment of low back pain and posterior pelvic pain in pregnancy: study protocol for a multicentre randomised placebo-controlled trial. Trials. 2014 Jul 16;15:288. doi: 10.1186/1745-6215-15-288.

    PMID: 25027493BACKGROUND
  • Vas J, Aguilar I, Perea-Milla E, Mendez C. Effectiveness of acupuncture and related techniques in treating non-oncological pain in primary healthcare--an audit. Acupunct Med. 2007 Jun;25(1-2):41-6. doi: 10.1136/aim.25.1-2.41.

    PMID: 17641567BACKGROUND
  • Vickers AJ, Cronin AM, Maschino AC, Lewith G, MacPherson H, Foster NE, Sherman KJ, Witt CM, Linde K; Acupuncture Trialists' Collaboration. Acupuncture for chronic pain: individual patient data meta-analysis. Arch Intern Med. 2012 Oct 22;172(19):1444-53. doi: 10.1001/archinternmed.2012.3654.

    PMID: 22965186BACKGROUND

MeSH Terms

Conditions

Low Back PainBack Pain

Interventions

AcetaminophenDiclofenacDiazepamHydrocodoneoxycodone-acetaminophenKetorolacKetorolac Tromethamine

Condition Hierarchy (Ancestors)

PainNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

AcetanilidesAnilidesAmidesOrganic ChemicalsAniline CompoundsAminesPhenylacetatesAcids, CarbocyclicCarboxylic AcidsBenzodiazepinonesBenzodiazepinesBenzazepinesHeterocyclic Compounds, 2-RingHeterocyclic Compounds, Fused-RingHeterocyclic CompoundsCodeineMorphine DerivativesMorphinansOpiate AlkaloidsAlkaloidsHeterocyclic Compounds, Bridged-RingHeterocyclic Compounds, 4 or More RingsPhenanthrenesPolycyclic Aromatic HydrocarbonsPolycyclic CompoundsIndomethacinIndoles

Study Officials

  • Timothy Bonjour, DSc

    Program Director

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
FED
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

September 7, 2018

First Posted

June 25, 2019

Study Start

February 22, 2016

Primary Completion

December 12, 2016

Study Completion

December 12, 2016

Last Updated

June 26, 2019

Record last verified: 2019-06